These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 19067739)

  • 1. Catastrophic tumour lysis syndrome following single dose of imatinib.
    Keane C; Henden A; Bird R
    Eur J Haematol; 2009 Mar; 82(3):244-5. PubMed ID: 19067739
    [No Abstract]   [Full Text] [Related]  

  • 2. Tumour lysis syndrome with acute renal failure during imatinib therapy.
    Ali R; Ozkalemkas F; Ozkan A; Ozcelik T; Ozkocaman V; Akdag I; Ozan U; Tunali A
    Leuk Res; 2007 Apr; 31(4):573-4. PubMed ID: 16782190
    [No Abstract]   [Full Text] [Related]  

  • 3. Imatinib-induced tumor lysis syndrome: report of a case and review of the literature.
    Chang H; Shih LY
    Chang Gung Med J; 2008; 31(5):510-4. PubMed ID: 19097599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor lysis syndrome after starting treatment with Gleevec in a patient with chronic myelogenous leukemia.
    Al-Kali A; Farooq S; Tfayli A
    J Clin Pharm Ther; 2009 Oct; 34(5):607-10. PubMed ID: 19744017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is there any protective effect on organs upon higher uric acid level in tumor lysis syndrome?
    Basturk A; Hacibekiroglu T; Akinci S; Dilek I; Atalay HV
    Ren Fail; 2011; 33(4):465. PubMed ID: 21529279
    [No Abstract]   [Full Text] [Related]  

  • 6. Halo nevi related to treatment with imatinib in a dermatofibrosarcoma protuberans patient.
    Fava P; Stroppiana E; Savoia P; Bernengo MG
    J Eur Acad Dermatol Venereol; 2010 Feb; 24(2):244-5. PubMed ID: 19694892
    [No Abstract]   [Full Text] [Related]  

  • 7. Tumor lysis syndrome after STI571 in Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Dann EJ; Fineman R; Rowe JM
    J Clin Oncol; 2002 Jan; 20(1):354-5. PubMed ID: 11773197
    [No Abstract]   [Full Text] [Related]  

  • 8. Lymphomatoid granulomatosis induced by imatinib-treatment.
    Yazdi AS; Metzler G; Weyrauch S; Berneburg M; Bitzer M; Müller-Hermelink HK; Röcken M
    Arch Dermatol; 2007 Sep; 143(9):1222-3. PubMed ID: 17875901
    [No Abstract]   [Full Text] [Related]  

  • 9. Negative results of an Italian Group for Mesothelioma (G.I.Me.) pilot study of single-agent imatinib mesylate in malignant pleural mesothelioma.
    Porta C; Mutti L; Tassi G
    Cancer Chemother Pharmacol; 2007 Jan; 59(1):149-50. PubMed ID: 16636799
    [No Abstract]   [Full Text] [Related]  

  • 10. A ZMYM2-FGFR1 8p11 myeloproliferative neoplasm with a novel nonsense RUNX1 mutation and tumor lysis upon imatinib treatment.
    Buijs A; van Wijnen M; van den Blink D; van Gijn M; Klein SK
    Cancer Genet; 2013 Apr; 206(4):140-4. PubMed ID: 23751892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Episodic angioedema with eosinophilia: successful treatment with imatinib.
    Scranton SE; Wild CA; England RW
    Ann Allergy Asthma Immunol; 2008 Feb; 100(2):172-4. PubMed ID: 18320923
    [No Abstract]   [Full Text] [Related]  

  • 12. A 51-year-old male CML patient with progressive hearing loss, confusion, ataxia, and aphasia during imatinib treatment.
    Janssen JJ; Berendse HW; Schuurhuis GJ; Merle PA; Ossenkoppele GJ
    Am J Hematol; 2009 Oct; 84(10):679-82. PubMed ID: 19658186
    [No Abstract]   [Full Text] [Related]  

  • 13. New Gleevec treatment approved.
    FDA Consum; 2002; 36(2):6. PubMed ID: 11989477
    [No Abstract]   [Full Text] [Related]  

  • 14. Imatinib mesylate.
    Davey MP
    Clin J Oncol Nurs; 2002; 6(2):118-20. PubMed ID: 11889677
    [No Abstract]   [Full Text] [Related]  

  • 15. Imatinib-induced erythroderma.
    Mathew T; Chandrashekar L; Pulimood S; Srivastava A
    Australas J Dermatol; 2007 Aug; 48(3):193-4. PubMed ID: 17680975
    [No Abstract]   [Full Text] [Related]  

  • 16. Approval summary: imatinib mesylate in the treatment of metastatic and/or unresectable malignant gastrointestinal stromal tumors.
    Cohen MH; Farrell A; Justice R; Pazdur R
    Oncologist; 2009 Feb; 14(2):174-80. PubMed ID: 19193781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imatinib-associated lichenoid eruption: acitretin treatment allows maintained antineoplastic effect.
    Dalmau J; Peramiquel L; Puig L; Fernández-Figueras MT; Roé E; Alomar A
    Br J Dermatol; 2006 Jun; 154(6):1213-6. PubMed ID: 16704665
    [No Abstract]   [Full Text] [Related]  

  • 18. [Nephrotoxicidad for imatinib].
    Díaz Rodríguez C; Vasco B
    Nefrologia; 2003; 23(3):273-4. PubMed ID: 12891946
    [No Abstract]   [Full Text] [Related]  

  • 19. [A case of recurrent gastrointestinal stromal tumor of the stomach with complete response to imatinib mesilate].
    Aoyama T; Saeki H; Samejima J; Fujii K; Ishikawa Y; Kawamoto M; Fujisawa J; Matsukawa H; Rino Y; Masuda M
    Gan To Kagaku Ryoho; 2009 Jun; 36(6):975-8. PubMed ID: 19542718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutaneous lichenoid eruption caused by imatinib mesylate in a Japanese patient with chronic myeloid leukaemia.
    Kawakami T; Kawanabe T; Soma Y
    Acta Derm Venereol; 2009; 89(3):325-6. PubMed ID: 19479144
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.